Berberine is a plant alkaloid with numerous biological activities. A large body of preclinical in vitro and in vivo studies support different pharmacological actions of berberine that could be potentially useful in the management of metabolic diseases associated to high cardiovascular disease risk, such as mixed hyperlipidaemia, insulin-resistance, metabolic syndrome and type 2 diabetes. Moreover, it seems that berberine exerts also antinflammatory and antiproliferative effects that could play a role in the development of atherosclerosis and its clinical consequences. Recently, the metabolic effects of berberine have been demonstrated also in humans, opening new perspectives for the use of this molecule in patient therapy. Larger and longer clinical studies needs to be carried out to implement the definition of the therapeutic role of berberine in humans.

Berberine: metabolic and cardiovascular effects in preclinical and clinical trials.

CICERO, ARRIGO FRANCESCO GIUSEPPE;
2009

Abstract

Berberine is a plant alkaloid with numerous biological activities. A large body of preclinical in vitro and in vivo studies support different pharmacological actions of berberine that could be potentially useful in the management of metabolic diseases associated to high cardiovascular disease risk, such as mixed hyperlipidaemia, insulin-resistance, metabolic syndrome and type 2 diabetes. Moreover, it seems that berberine exerts also antinflammatory and antiproliferative effects that could play a role in the development of atherosclerosis and its clinical consequences. Recently, the metabolic effects of berberine have been demonstrated also in humans, opening new perspectives for the use of this molecule in patient therapy. Larger and longer clinical studies needs to be carried out to implement the definition of the therapeutic role of berberine in humans.
File in questo prodotto:
File Dimensione Formato  
NDS_6084_Metabolic_and_cardiovascular_effects_of_berberine_091009.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale (CCBYNC)
Dimensione 344.52 kB
Formato Adobe PDF
344.52 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11585/106098
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact